Medical Equipment

Lichen Planus Market Outlook Highlighting Key Drivers And Market Evolution

April 14, 2026April 14, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Anticipated Rise In Market Value Of The Lichen Planus Market During The Forecast Period?

The market for lichen planus has demonstrated significant expansion in recent years. Projections indicate it will expand from $1.26 billion in 2025 to $1.35 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.1%. This historical growth is attributable to factors such as increased diagnosis of autoimmune skin disorders, the availability of corticosteroid therapies, the expansion of dermatology specialty clinics, enhanced clinical awareness of lichen planus, and the utilization of phototherapy techniques.

The lichen planus market size is anticipated to undergo significant expansion over the next few years, projected to reach $1.76 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.8%. This growth during the forecast period is influenced by a growing demand for advanced immunotherapies, an increasing emphasis on long-term symptom management, the broadening of biologic treatment research, greater integration of digital dermatology tools, and developments in targeted anti-inflammatory drugs. Major developments expected in the forecast period include the increasing adoption of targeted immunomodulatory therapies, a rising use of combined topical and systemic treatments, an intensified focus on chronic disease management, the expansion of personalized dermatology care, and improved patient education and disease monitoring.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/lichen-planus-global-market-report

Which Drivers Are Supporting The Lichen Planus Market Growth?

The expanding occurrence of autoimmune diseases is projected to boost the growth of the lichen planus market. Autoimmune diseases are characterized by the immune system mistakenly attacking the body’s healthy cells, including conditions like rheumatoid arthritis, lupus, type 1 diabetes, multiple sclerosis, and psoriasis. The increasing prevalence of these diseases is linked to genetic predispositions, as specific gene variations impact immune system function and lead to connective tissue abnormalities. This rising incidence of autoimmune diseases not only indicates a broader issue in immune regulation but also contributes to an elevated number of lichen planus cases. For illustration, in June 2024, data from the Australian Institute of Health and Welfare, an Australia-based government agency, showed that approximately 514,000 (2.0%) people lived with rheumatoid arthritis in 2022, which represented 2.0% of the overall disease burden and 16% of the musculoskeletal conditions burden in 2023. Furthermore, 1,322 deaths (5.1 deaths per 100,000 population) were recorded in 2022 due to rheumatoid arthritis, accounting for 0.7% of all deaths. Therefore, the increasing prevalence of autoimmune diseases is a significant driver for the growth of the lichen planus market.

How Is The Lichen Planus Market Categorized Across Its Segment Groups?

The lichen planus market covered in this report is segmented –

1) By Disease Type: Lichen Planus, Oral Lichen Planus, Genital Lichen Planus, Lichen Planus Pigmentosus

2) By Treatment Type: Topical Therapies, Systemic Therapies, Phototherapy

3) By Route Of Administration: Topical, Oral, Intravenous

4) By End User: Hospitals, Homecare, Specialty Clinics, Other End-Users

Subsegments:

1) By Lichen Planus: Papular Lichen Planus, Hypertrophic Lichen Planus, Actinic Lichen Planus, Linear Lichen Planus, Annular Lichen Planus

2) By Oral Lichen Planus: Reticular Oral Lichen Planus, Erosive Oral Lichen Planus, Atrophic Oral Lichen Planus, Plaque-Like Oral Lichen Planus, Bullous Oral Lichen Planus

3) By Genital Lichen Planus: Erosive Genital Lichen Planus, Papular Genital Lichen Planus, Annular Genital Lichen Planus, Vulvovaginal-Gingival Syndrome

4) By Lichen Planus Pigmentosus: Diffuse Lichen Planus Pigmentosus, Blotchy Lichen Planus Pigmentosus, Linear Lichen Planus Pigmentosus, Perifollicular Lichen Planus Pigmentosus, Flexural Lichen Planus Pigmentosus

Which Trends Are Expected To Impact The Lichen Planus Market?

Major companies operating in the lichen planus market are concentrating on creating innovative solutions like liposomal formulations to enhance targeted drug delivery and lessen systemic side effects. Liposomal formulations are drug delivery systems where active ingredients are encapsulated within liposomes, which are tiny spherical vesicles composed of lipid bilayers that improve drug stability, boost absorption, and enable targeted delivery with reduced systemic side effects. For instance, in February 2025, Lipella Pharmaceuticals Inc., a US-based biotechnology company specializing in developing treatments for serious diseases, received US Food and Drug Administration approval for an expanded access program (EAP) for LP-310. This is a liposomal formulation of tacrolimus designed to offer targeted relief for oral lichen planus (OLP) patients while minimizing systemic exposure. This program allows patients with serious or life-threatening conditions and unmet medical needs to access treatments outside of clinical trials before they are officially approved.

Which Firms Are Influencing Competition In The Lichen Planus Market?

Major companies operating in the lichen planus market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc, AbbVie Inc., Sanofi SA, Bristol-Myers Squibb Company, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Dr. Reddy’s Laboratories Ltd, Amneal Pharmaceuticals Inc., Hikma Pharmaceuticals plc, LEO Pharma A/S, Basilea Pharmaceutica Ltd., UCB S.A., Almirall SA, Lipella Pharmaceuticals Inc.

Get The Full Lichen Planus Market Report:

https://www.thebusinessresearchcompany.com/report/lichen-planus-global-market-report

Which Region Is The Top Contributor To The Lichen Planus Market By Share?

North America was the largest region in the lichen planus market in 2025. The regions covered in the lichen planus market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Lichen Planus Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/lichen-planus-global-market-report

Browse Through More Reports Similar to the Global Lichen Planus Market 2026, By The Business Research Company

Luxury Skincare Market Report 2026

https://www.thebusinessresearchcompany.com/report/luxury-skincare-global-market-report

Liraglutide Market Report 2026

https://www.thebusinessresearchcompany.com/report/liraglutide-global-market-report

Sugar And Confectionery Products Market Report 2026

https://www.thebusinessresearchcompany.com/report/sugar-and-confectionery-products-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795